At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.
Patent # | Description |
---|---|
US-9,714,399 |
Preparation of lactylates directly from oil A process includes the transesterification of a fatty acid triglyceride ester with a salt of hydroxycarboxylic acid without making use of organic solvents. The... |
US-9,714,394 |
Method for producing ashless coal A method for producing an ashless coal includes a slurry preparation, an extraction, a separation, an ashless coal acquirement, and a by-product acquirement. In... |
US-9,714,379 |
Highly luminescent semiconductor nanocrystals A method of making a semiconductor nanocrystal can include contacting an M-containing compound with an X donor having the formula X(Y(R).sub.3).sub.3, where X... |
US-9,714,373 |
Urea hydrochloride compositions A composition comprising a base, nonylphenol, at least one quaternary ammonium compound, and glycol ether EB is provided in a method for solubilizing calcium... |
US-9,714,367 |
Light curable adhesives A system that includes a polymer adhesive containing metallic or other nanoparticles that resonate upon the application of electromagnetic radiation to product... |
US-9,714,359 |
Remediation of yellowing in a coatings formulation containing a sorbate
ester or a sorbamide coalescent The present invention is a composition comprising a stable aqueous dispersion of polymer particles and a sorbate ester, which is a liquid at 20.degree. C. and... |
US-9,714,353 |
Ink composition, ink set, and image formation method An ink composition contains the following (A) to (D): (A) a polymerizable compound having an ethylenically unsaturated group, (B) a photopolymerization... |
US-9,714,340 |
Flame-retardant polybutylene terephthalate resin composition A halogen-free flame retardant polybutylene terephthalate resin composition contains 5 to 80 parts by weight of a phosphorus flame retardant (B) having a... |
US-9,714,334 |
Integrated process for treating recycled PET and PTT materials A process for producing a polyester polyol comprising reacting a recycle stream selected from recycled PET carpet, carpet fiber, containers, textiles, articles... |
US-9,714,333 |
Single and twin screw extruders with ultrasound horns for decrosslinking
and devulcanization Processes for decrosslinking crosslinked plastic and devulcanizing vulcanized rubber include advancing such materials through single screw or twin screw... |
US-9,714,330 |
Method of manufacturing polystyrene foam with polymer processing additives Disclosed is a method for making polystyrene foam which utilizes one or more atmospheric gases, particularly CO.sub.2, as the blowing agent in combination with... |
US-9,714,297 |
Human antibodies against tissue factor and methods of use thereof Isolated human monoclonal antibodies which bind to human TF and related antibody-based compositions and molecules, are disclosed. Also disclosed are... |
US-9,714,287 |
Anti-IL-23 antibody compositions An anti-IL-23 antibody, including isolated nucleic acids that encode at least one anti-IL-23 antibody, vectors, host cells, transgenic animals or plants, and... |
US-9,714,283 |
Compositions and methods for the treatment of immunodeficiency The present invention relates to compositions and methods for the treatment of immunodeficiency (e.g., primary immunodeficiency disease). In particular, the... |
US-9,714,280 |
HLA G-modified cells and methods Disclosed herein are genetically modified cells expressing HLA-G (e.g., cell surface HLA-G) persistently, and nucleic acid compositions useful for generating... |
US-9,714,278 |
Use of ICOS-based CARs to enhance antitumor activity and CAR persistence The present invention provides compositions and methods for treating cancer in a human. The invention includes administering a genetically modified Th17 cell to... |
US-9,714,277 |
Pegylated glucagon and GLP-1 co-agonists for the treatment of obesity This disclosure provides pegylated GLP-1/glucagon agonist peptides for the treatment of metabolic diseases, e.g., obesity. |
US-9,714,276 |
Growth differentiation factor 15 (GDF-15) polypeptides GDF15 polypeptides, constructs comprising GDF15, and mutants thereof are provided. In various embodiments the GDF15 polypeptides, constructs comprising GDF15,... |
US-9,714,265 |
Mutagenic nucleoside analogs and uses thereof The present disclosure provides nucleoside analogs of Formula (I) or (II). The nucleoside analogs are expected to show multiple tautomerism and may increase the... |
US-9,714,264 |
Method for working up an aqueous lignin containing solution A method for working up an aqueous, alkaline-alcoholic and lignin containing solution via nanofiltration, wherein a permeate and a retentate are obtained, which... |
US-9,714,262 |
Composition for forming passivation layer, semiconductor substrate having
passivation layer, method of... A composition for forming a passivation layer, comprising a compound represented by Formula (I): M(OR.sup.1).sub.m. In Formula (I), M comprises at least one... |
US-9,714,260 |
Asymmetrical Si rhodamine and rhodol synthesis [Problem] To provide: a compound resulting from substituting with a silicon atom the oxygen atom at position 10 of a xanthene ring site of a rhodamine of which... |
US-9,714,258 |
Diaryl macrocycles as modulators of protein kinases The present invention relates to certain diaryl macrocyclic compounds, pharmaceutical compositions containing them, and methods of using them, including methods... |
US-9,714,257 |
Therapeutic agent for motor disorders Provided are an agent for the treatment and/or prophylaxis of a movement disorder, the agent for the treatment and/or prophylaxis wherein the movement disorder... |
US-9,714,251 |
Imidazotriazine derivatives as modulators of TNF activity A series of substituted imidazo[1,2-b][1,2,4]triazine derivatives of formula (I), being potent modulators of human TNFa activity, are accordingly of benefit in... |
US-9,714,247 |
Multiple kinase pathway inhibitors Kinase with inhibitory activity against kinases disposed in multiple signaling pathways and their therapeutic uses. |
US-9,714,246 |
[9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido-[2,1-a]is-
oquinolin-2-yl]methanol and... Compounds having a structure of formula (I), including stereoisomers and pharmaceutically acceptable salts and solvates thereof: ##STR00001## wherein R.sub.1... |
US-9,714,241 |
Cyclopropanamine compound and use thereof The present invention provides a compound having a lysine-specific demethylase-1 inhibitory action, and useful as a medicament such as a prophylactic or... |
US-9,714,238 |
Therapeutic agents for ocular hypertension This invention provides well defined 6-alkyl or hydroxyalkyl-1-naphthamide or quinoline compounds for treating glaucoma or ocular hypertension. |
US-9,714,232 |
Substituted piperazine compounds and methods of use thereof Provided herein are novel piperazine compounds and pharmaceutical compositions thereof comprising the piperazine compounds for inhibiting serotonin reuptake... |
US-9,714,231 |
Pyrrolidine GPR40 modulators The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as... |
US-9,714,226 |
Hydrazide containing nuclear transport modulators and uses thereof The invention generally relates to nuclear transport modulators, e.g., CRM1 inhibitors, and more particularly to a compound represented by structural formula I:... |
US-9,714,225 |
Processes for the preparation of lorcaserin The present invention relates to stable crystalline Form I of lorcaserin hydrochloride of Formula (IA) and processes for its preparation. The invention also... |
US-9,714,214 |
Natural oil derivatives including (meth)acrylate functional groups A compound has Structure I: ##STR00001## where R.sub.1 and R.sub.2 independently are C.sub.2-C.sub.12 alkyl groups, R.sub.3 and R.sub.3' independently are H... |
US-9,714,212 |
Chemical compounds derived from normemantine and use of same in the
medical field The present invention concerns novel chemical compounds corresponding to formulae (I) and (II): (I) (II) which, when marked with fluorine-18, can be used as... |
US-9,714,209 |
Estolide compound and method for preparing the same A method for preparing an estolide compound and an estolide compound prepared thereby are disclosed. The method for preparing an estolide compound includes:... |
US-9,714,208 |
Catalysts conversion of hydroxypropionic acid or its derivatives to
acrylic acid or its derivatives Methods for catalytically dehydrating hydroxypropionic acid, hydroxypropionic acid derivatives, or mixtures thereof to acrylic acid, acrylic acid derivatives,... |
US-9,714,201 |
Isononylamines from 2-ethylhexanol, processes for their preparation, and
their use Process for preparing isononylamines starting out from 2-ethylhexanol, characterized in that (a) 2-ethylhexanol is dehydrated in the presence of a catalyst to... |
US-9,714,200 |
Process for preparing ethylene and other olefins from aqueous solutions of
the corresponding alcohols The invention relates to a process for the continuous production of one or more olefins from an aqueous solution of corresponding alcohol(s) including:... |
US-9,714,196 |
Method for controlling NOx concentration in exhaust gas in combustion
facility using pulverized coal A method for controlling an NOx concentration in an exhaust gas in a combustion facility by: measuring a reaction velocity k.sub.i of each of a plurality of... |
US-9,714,194 |
Methods for controlled laser-induced growth of glass bumps on glass
articles A method for controlling formation of glass bumps in a glass article with laser-irradiation without the use of a growth-limiting structure. Standard deviation... |
US-9,714,191 |
Process for coating a glass substrate with an aqueous fluoropolymer
coating The invention relates to an process for coating a glass substrate with an environmentally friendly aqueous, fluoropolymer coating composition. The process... |
US-9,714,188 |
Ion exchangeable glasses with high crack initiation threshold Alkali boroaluminosilicate glasses with high resistance to crack initiation and damage due to sharp impact are provided. The glass compositions have melting and... |
US-9,714,186 |
Bending of sheets of glass running on a bed of rolls A device for bending sheets of glass running between a bed of upper rolls and a bed of lower rolls forming a shaping bed that pinches the sheets as they run,... |
US-9,714,184 |
Electrostatically pinned glass roll, methods and apparatus for making A roll (10) of glass ribbon (20) and an interleaf material (40) disposed in alternating layers, wherein a layer of the interleaf material is pinned to an... |
US-9,714,183 |
Water walls for life support A method and associated system for processing waste gases, liquids and solids, produced by human activity, to separate (i) liquids suitable for processing to... |
US-9,714,180 |
Composite material for absorbing and remediating contaminants and method
of making same The mat is formed of a saprophytic fungal strain and/or budding yeast, and a mass of particles wherein the fungus is characterized in producing an enzyme... |
US-9,714,179 |
Process for feed-water oxygenating treatment in boiler in power station The present invention provides a process of oxygenated feed-water treatment of boilers in power station, carried out under an OT treatment process, suitable for... |
US-9,714,173 |
Gyroidal mesoporous carbon materials and methods thereof The present invention relates to, inter alia, gyroidal mesoporous carbon materials and methods of use and manufacture thereof. In one embodiment, the present... |
US-9,714,169 |
Catalyst and process for thermo-neutral reforming of liquid hydrocarbons The invention relates to a four-component catalyst and a seven-component catalyst and refractory supports for use in the thermoneutral reforming of... |